Who Paid My Doc
Ronald Barrette
Thoracic Surgery (Cardiothoracic Vascular Surgery) Phenix City, AL Doctor of Osteopathy
NPI 1942256623 CMS profile 389783
1810 Stadium Dr, Suite 130, Phenix City, AL 36867
General payments
$32,520
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Ronald Barrette of Phenix City, AL is reported in the CMS Open Payments database as having received $32,520 across 75 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 85th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $14 | 1 | |
| 2023 | General | $1,587 | 3 | |
| 2022 | General | $17,829 | 43 | |
| 2021 | General | $13,057 | 26 | |
| 2020 | General | $33 | 2 |
Beside peers
- Ronald Barrette
- Thoracic Surgery (Cardiothoracic Vascular Surgery) median
- Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
- National median
In program year 2025, general payments to Ronald Barrette were reported at $14. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.
Show as a table
| Year | Ronald Barrette | Thoracic Surgery (Cardiothoracic Vascular Surgery) median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $886 | $178–$3,167 | $163 |
| 2020 | $33 | $341 | $108–$1,605 | $114 |
| 2021 | $13,057 | $453 | $125–$1,886 | $132 |
| 2022 | $17,829 | $695 | $180–$2,566 | $149 |
| 2023 | $1,587 | $745 | $205–$2,662 | $160 |
| 2024 | $0 | $799 | $214–$2,967 | $164 |
| 2025 | $14 | $791 | $208–$3,074 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 13 drugsPart D claims
210
Drug cost
$1,991
Branded share of claims
17.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 23 | $566 | |
| Diclofenac Sodium | Generic | 21 | $314 | |
| Omeprazole | Generic | 11 | $212 | |
| Ibuprofen | Generic | 16 | $149 | |
| Azithromycin | Generic | 29 | $143 | |
| Gabapentin | Generic | 11 | $133 | |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | Brand | 13 | $107 | |
| Rosuvastatin Calcium | Generic | 14 | $92 | |
| Atorvastatin Calcium | Generic | 13 | $78 | |
| Meloxicam | Generic | 14 | $74 |
The 10 drugs with the highest cost, of 13 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.
Records
75 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Related records
Thoracic Surgery (Cardiothoracic Vascular Surgery) in Alabama
Practitioners in the same specialty and state, ranked by reported value.
All Thoracic Surgery (Cardiothoracic Vascular Surgery)
Everyone recorded under this specialty, nationwide.
Doctors in Alabama
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.